Cargando…
Case of ST-Elevation Myocardial Infarction in a 32-Year-Old Male Receiving Bleomycin, Etoposide, and Cisplatin Chemotherapy for Embryonal Carcinoma
Myocardial infarction in young individuals has unique risk factors compared to the older population. Along with usual risk factors, one should explore causes such as recreational drug use, medication-induced myocardial infarction, and spontaneous coronary artery dissection. Here, we present the case...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327993/ https://www.ncbi.nlm.nih.gov/pubmed/37425586 http://dx.doi.org/10.7759/cureus.40089 |
_version_ | 1785069704649375744 |
---|---|
author | Bassil, Emmanuel Singh, Harjinder Ahmed, Omair Parikh, Shamik |
author_facet | Bassil, Emmanuel Singh, Harjinder Ahmed, Omair Parikh, Shamik |
author_sort | Bassil, Emmanuel |
collection | PubMed |
description | Myocardial infarction in young individuals has unique risk factors compared to the older population. Along with usual risk factors, one should explore causes such as recreational drug use, medication-induced myocardial infarction, and spontaneous coronary artery dissection. Here, we present the case of a 32-year-old male who presented with chest pain and was found to have complete thrombotic occlusion of the right coronary artery. He recently started receiving chemotherapy with bleomycin, etoposide, and cisplatin (PEB). In the absence of other risk factors and previous reports of similar cardiotoxicity with bleomycin, the patient was deemed to have an adverse effect from the chemotherapy regimen. |
format | Online Article Text |
id | pubmed-10327993 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-103279932023-07-08 Case of ST-Elevation Myocardial Infarction in a 32-Year-Old Male Receiving Bleomycin, Etoposide, and Cisplatin Chemotherapy for Embryonal Carcinoma Bassil, Emmanuel Singh, Harjinder Ahmed, Omair Parikh, Shamik Cureus Cardiology Myocardial infarction in young individuals has unique risk factors compared to the older population. Along with usual risk factors, one should explore causes such as recreational drug use, medication-induced myocardial infarction, and spontaneous coronary artery dissection. Here, we present the case of a 32-year-old male who presented with chest pain and was found to have complete thrombotic occlusion of the right coronary artery. He recently started receiving chemotherapy with bleomycin, etoposide, and cisplatin (PEB). In the absence of other risk factors and previous reports of similar cardiotoxicity with bleomycin, the patient was deemed to have an adverse effect from the chemotherapy regimen. Cureus 2023-06-07 /pmc/articles/PMC10327993/ /pubmed/37425586 http://dx.doi.org/10.7759/cureus.40089 Text en Copyright © 2023, Bassil et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Cardiology Bassil, Emmanuel Singh, Harjinder Ahmed, Omair Parikh, Shamik Case of ST-Elevation Myocardial Infarction in a 32-Year-Old Male Receiving Bleomycin, Etoposide, and Cisplatin Chemotherapy for Embryonal Carcinoma |
title | Case of ST-Elevation Myocardial Infarction in a 32-Year-Old Male Receiving Bleomycin, Etoposide, and Cisplatin Chemotherapy for Embryonal Carcinoma |
title_full | Case of ST-Elevation Myocardial Infarction in a 32-Year-Old Male Receiving Bleomycin, Etoposide, and Cisplatin Chemotherapy for Embryonal Carcinoma |
title_fullStr | Case of ST-Elevation Myocardial Infarction in a 32-Year-Old Male Receiving Bleomycin, Etoposide, and Cisplatin Chemotherapy for Embryonal Carcinoma |
title_full_unstemmed | Case of ST-Elevation Myocardial Infarction in a 32-Year-Old Male Receiving Bleomycin, Etoposide, and Cisplatin Chemotherapy for Embryonal Carcinoma |
title_short | Case of ST-Elevation Myocardial Infarction in a 32-Year-Old Male Receiving Bleomycin, Etoposide, and Cisplatin Chemotherapy for Embryonal Carcinoma |
title_sort | case of st-elevation myocardial infarction in a 32-year-old male receiving bleomycin, etoposide, and cisplatin chemotherapy for embryonal carcinoma |
topic | Cardiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327993/ https://www.ncbi.nlm.nih.gov/pubmed/37425586 http://dx.doi.org/10.7759/cureus.40089 |
work_keys_str_mv | AT bassilemmanuel caseofstelevationmyocardialinfarctionina32yearoldmalereceivingbleomycinetoposideandcisplatinchemotherapyforembryonalcarcinoma AT singhharjinder caseofstelevationmyocardialinfarctionina32yearoldmalereceivingbleomycinetoposideandcisplatinchemotherapyforembryonalcarcinoma AT ahmedomair caseofstelevationmyocardialinfarctionina32yearoldmalereceivingbleomycinetoposideandcisplatinchemotherapyforembryonalcarcinoma AT parikhshamik caseofstelevationmyocardialinfarctionina32yearoldmalereceivingbleomycinetoposideandcisplatinchemotherapyforembryonalcarcinoma |